# An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy

> **NCT00505284** · PHASE2,PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 352 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** Placebo
- **DRUG:** E2007 (2 mg)
- **DRUG:** E2007 (4 mg)
- **DRUG:** E2007 (6 mg)
- **DRUG:** E2007 (8 mg)

## Key facts

- **NCT ID:** NCT00505284
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2014-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505284, "An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00505284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*